(40) reported a case with EGFR L861Q mutation in both SCLC and AC components, in which multiple brain metastases and enlarged mediastinal lymph nodes subsequently appeared after second-line erlotinib treatment. The gene discussed is EGFR; the disease is small cell lung carcinoma.